Table 4.
True positive patients (N = 997), n (%) | False negative patients (N = 1002), n (%) | |
---|---|---|
Age | ||
18–64 | 474 (47.5) | 486 (48.5) |
65–74 | 227 (22.8) | 259 (25.9) |
75–84 | 191 (19.2) | 164 (16.4) |
≥85 | 105 (10.5) | 93 (9.3) |
Sex | ||
Female | 505 (50.7) | 456 (45.5) |
Male | 492 (49.4) | 546 (54.5) |
Race | ||
White | 428 (42.9) | 427 (42.6) |
Black | 140 (14.0) | 130 (13.0) |
Asian | 30 (3.0) | 36 (3.6) |
Other/declined | 399 (40.0) | 409 (40.8) |
Charlson comorbidity index | ||
0 | 91 (9.1) | 244 (24.4) |
1–2 | 246 (24.7) | 248 (24.8) |
≥3 | 660 (66.2) | 510 (50.9) |
Cancer diagnosis | 521 (52.3) | 308 (30.7) |
ICU admission | 366 (36.7) | 494 (49.3) |
Hospital length of stay, median (IQR) | 12 (7–21) | 18 (9–39) |
Discharge destination | ||
Home | 79 (7.9) | 145 (14.5) |
Home with health services | 169 (17.0) | 207 (20.7) |
Skilled nursing facility | 88 (8.8) | 126 (12.6) |
Hospice | 248 (24.9) | 103 (10.3) |
Other facility | 40 (4.0) | 59 (5.9) |
Rehabilitation facility | 17 (1.7) | 55 (5.5) |
Other | 4 (0.4) | 6 (0.6) |
Died in hospital | 352 (35.3) | 301 (30.0) |
Number of diagnoses, median (IQR) | 19 (15–23) | 18 (11–23) |